department of defense multiple sclerosis research program
applications to the fiscal year 2016 (fy16) multiple sclerosis research program (msrp) are being solicited for the defense health agency, research, development, and acquisition (dha rda) directorate, by the u.s. army medical research acquisition activity (usamraa). as directed by the office of the assistant secretary of defense for health affairs (oasd[ha]), the dha rda directorate manages the defense health program (dhp) research, development, test, and evaluation (rdt&e) appropriation. the managing agent for this program announcement/funding opportunity is the congressionally directed medical research programs (cdmrp). the msrp, established in fy09, is dedicated to supporting pioneering concepts and high-impact research that are relevant to the prevention, etiology, pathogenesis, assessment, and treatment of multiple sclerosis (ms) to ultimately lessen its personal and societal impact. appropriations for the msrp from fy09 through fy15 totaled $33.1 million (m). the fy16 appropriation is $6m.
funding opportunities under this program:
- pilot clinical trial award
- investigator initiated research award
- exploration - hypothesis development award